Hints and tips:
...Some retail investors were undeterred: “FEAR NOT #phunarmy this is the insiders and institutions trying wash out us retail investors hold strong and I’m adding on these dips,” said one poster in the stock...
...Here’s more on the regions driving a nascent recovery in the M&A market....
...I’m not sure what to think about this....
...And I’m slightly sceptical that anyone else knows how to do it, either. But I’m open to suggestions....
...The new paper, by Jeremiah Green of Texas A&M and John Hand of University of North Carolina, argues that at least on the ethnic diversity side, the studies just don’t hold up....
...I’m not sure of the market relevance of either point, but there you go. Email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...I’m not sure if the second-tier social media companies are profitable, even when their revenues rise into the billions....
...Brewer, one of the few African-American women to run a company in the S&P 500, arrived as pharmacy chains were being boosted by the strong early uptake of Covid-19 vaccines....
...“What used to take us three weeks can take us three hours and clients currently pay on the time taken, not the output,” says S4’s Sorrell....
...“But Dai-ichi Life is clearly on the conservative side and people will look at it and say that’s Japan Inc. It’s great news for M&A in Japan.”...
...But any barriers to M&A would make it harder for pharma giants to smooth their earnings and pay generous dividends....
...Lawyer fee awards have become a hot topic in courts in Delaware, where more than 300 S&P 500 companies are incorporated....
...t=Y9t0T-RnJMxWG5hi8C5-OA&s=19 Further reading:— Putting a price on Tesla post Musk (FTAV)— The Tesla financial complex (FT)...
...But I’m not sure it’s more complicated....
...“We started to observe a very visible [rise]” in pharmacies’ sales, Li tells the Financial Times....
...Meanwhile on the stage, Stephen Sondheim’s Pacific Overtures and Kimber Lee’s satirical untitled f*ck m*ss s**gon play exemplify a more critical or contested perspective on postwar Asian narratives....
...Reiner encouraged newer covered call ETF issuers to be “slightly creative” when designing products and said he was “not really against them, but I’m also not rooting for them”....
...The FTC argued that Amgen could use the rebates it pays on its “blockbuster” drugs to press insurance companies and pharmacy benefit managers into paying for two of Horizon’s medicines: Tepezza for an autoimmune...
...“There is a thirst for new paper, and you’re not getting that through new M&A,” says Muthukrishnan....
...“I’m glad the FTC is looking at this,” Schleifer told the Financial Times US pharma and biotech summit in New York....
...But I’m not sure, and I’d be keen to hear from readers. One good read The natural gas industry in America is absolutely wild....
...I don’t know what became of those companies, but I’m assuming it wasn’t good, and that it took less than five years....
...In 2007, Greenhill recorded annual revenue of $400mn when the S&P 500 was around 1,500. Today the index is above 4,000. Yet Greenhill never again exceeded $330mn in annual revenue....
...Shaken by the pharmacy hold-up, Greta, who “like[s] knowing people’s secrets”, takes a job transcribing the sessions of a local sex and relationship coach....
...I’m not sure, but it is a good subject for further research. One good read Bumble is diversifying into the “ecosystem of love”....
International Edition